RenovoRx, Inc. (RNXT) - Latest Market Data

Price & Market Data

Price: $0.87

Daily Change: -$0.0116 / 1.33%

Daily Range: $0.87 - $0.911

Market Cap: $39,754,884

Daily Volume: 162,506

Performance Metrics

1 Week: 2.33%

1 Month: -8.78%

3 Months: -7.37%

6 Months: 11.11%

1 Year: -29.03%

YTD: 2.60%

About RenovoRx, Inc. (RNXT)

Get the latest on RenovoRx, Inc. (RNXT). Priced at 0.87, with a daily shift of -$0.0116 / 1.33%. Market cap: 39,754,884. Crucial performance data includes YTD (2.60%) and 1-month (-8.78%) returns.

Company Details

Employees: 17

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

RenovoRx, Inc., a clinical-stage biopharmaceutical company, engages in developing targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is chemotherapy gemcitabine, which is provided through RenovoCath that is in Phase III clinical trials for the treatment of locally advanced pancreatic cancer. The company was founded in 2009 and is headquartered in Mountain View, California.

Selected stocks

Energy Focus, Inc. (EFOI)

U.S. Global Investors, Inc. (GROW)

Sentage Holdings Inc. (SNTG)

Maris-Tech Ltd. (MTEK)